Knowledge, attitudes, and acceptance toward COVID-19 vaccine of gynecologic cancer patients in Thailand: A Multicenter study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220214006

Enrollment

1200

Registered

2022-02-14

Start date

2022-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid vaccine acceptance in gynecologic cancer patients covid-19, gynecologic cancer

Interventions

Patient diagnosed with gynecologic cancer during treatment or follow-up

Prevention

Gynecologic cancer patient

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women diagnosed with gynecologic cancer and can understand Thai language.

Exclusion criteria

Exclusion criteria: received Covid-19 vaccine before diagnosed with gynecologic cancer

Design outcomes

Primary

Measure	Time frame
Covid-19 vaccine acceptance At recruitment score (report in mean/median)	—

Secondary

Measure	Time frame
Knowledge about Covid-19 vaccine At recruitment score (report in mean/median)	—

Countries

Thailand

Contacts

Public ContactPrapaporn Suprasert

Chiang Mai university

psuprase@gmail.com6653935552

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026